The accumulation of OPN in the ECM during the ALS progression (Figs 3 and 4) prompted us to study possible autocrine or paracrine actions on MNs mediated via OPN’s receptors, αvβ3 integrin and/or CD4443, 44. The gene discussed is SPP1; the disease is amyotrophic lateral sclerosis.